MedTrace Logo

Retrospective Case Series - OSSIX Volumax Collagen Xenograft Scaffolding

NCT06187805 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2024-01-05

No results posted yet for this study

Summary

This study is designed as a retrospective, single center study. Up to 15 participants who had a transcrestal sinus elevation and implant placement using autogenous bone supporting an OSSIX Volumax collagen xenograft scaffolding will be enrolled. The study will include data collection from medical records and data collected at a follow up visit between January 2019 and March 2023.

Conditions

  • Dental Implants

Interventions

DEVICE

OSSIX Volumax

OSSIX Volumax is used in combination with autogenous bone collected during preparation of the implant osteotomy.

Sponsors & Collaborators

  • Old Orchard Periodontics and Implant Dentistry LTD

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-16
Primary Completion
2024-01-01
Completion
2024-02-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06187805 on ClinicalTrials.gov